Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $209.5 million.

  • Cellebrite DI's Shares Outstanding (Diluted Average) rose 10.16% to $209.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $209.5 million, marking a year-over-year increase of 10.16%. This contributed to the annual value of $209.5 million for FY2024, which is 10.16% up from last year.
  • Per Cellebrite DI's latest filing, its Shares Outstanding (Diluted Average) stood at $209.5 million for FY2024, which was up 10.16% from $190.2 million recorded in FY2023.
  • Cellebrite DI's 5-year Shares Outstanding (Diluted Average) high stood at $209.5 million for FY2024, and its period low was $190.2 million during FY2023.
  • For the 3-year period, Cellebrite DI's Shares Outstanding (Diluted Average) averaged around $198.3 million, with its median value being $195.4 million (2022).
  • Per our database at Business Quant, Cellebrite DI's Shares Outstanding (Diluted Average) fell by 2.68% in 2023 and then climbed by 10.16% in 2024.
  • Yearly analysis of 4 years shows Cellebrite DI's Shares Outstanding (Diluted Average) stood at $199.1 million in 2021, then fell by 1.85% to $195.4 million in 2022, then decreased by 2.68% to $190.2 million in 2023, then grew by 10.16% to $209.5 million in 2024.